Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous dexmedetomidine + esketamine infusion in ALS palliative care
2018-000142-18Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine and esketamine in amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS), sponsored by Turku University Hospital. Started May 2018; status: completed.
02
Drugs
dexmedetomidineesketamine
03
Conditions
amyotrophic lateral sclerosis (ALS)primary lateral sclerosis (PLS)
Beyond the preview
Go deeper on 2018-000142-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000142-18.